European Infection Control Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The European infection control market encompasses sterilizers, disinfectants, personal protective equipment, and reusable medical device reprocessing systems used across hospitals, clinics, and long-term care facilities. In 2025, the market stands at approximately $15.03 billion, representing a significant portion of the broader global infection control market valued at roughly $55.3 billion that same year. Multiple research and advisory firms track this sector with forecasts extending through 2030-2034, with consensus estimates pointing toward market sizes between $20.58 billion and $26.71 billion by the early 2030s.

• •European market valued at approximately $15.03 billion in 2025, representing roughly 27% of the global $55.3 billion infection control market
• •Consensus forecasts project values between $20.58 billion and $26.71 billion by 2030-2034, depending on forecast scope
• •CAGR estimates from market researchers range from 6.2% to 6.6%, with a midpoint near 6.45%

Increasing volumes of surgical procedures across Europe are a primary demand driver, as each operation requires strict sterilization protocols and infection prevention measures. Stringent regulatory frameworks enforced by agencies such as the European Centre for Disease Prevention and Control mandate rigorous infection prevention standards across healthcare facilities. Rising awareness and reporting of healthcare-associated infections (HAIs) continue to push healthcare providers toward investing in more advanced infection control technologies and consumables.

• •Growing volume of surgical procedures in European hospitals driving demand for sterilization and high-level disinfection products
• •Rising incidence of healthcare-associated infections prompting healthcare providers to upgrade infection prevention infrastructure
• •Advancements in reprocessing technologies and automated sterilization systems encouraging facility-level adoption

The market is commonly segmented by product type, including sterilizers (steam, dry heat, chemical, and radiation-based), disinfectants and antiseptics, and reusable medical device reprocessing systems, as well as by end-user facility type. Geographically, Western Europe including Germany, France, the United Kingdom, and the Benelux countries holds the largest share, supported by well-established healthcare infrastructure and strict regulatory enforcement. Eastern European markets are expected to see relatively faster growth as healthcare systems modernize and infection prevention standards converge with Western European norms.

• •Western Europe holds the largest market share, driven by advanced healthcare infrastructure and strict compliance requirements in Germany, France, the UK, and Benelux nations
• •Eastern Europe is emerging as a higher-growth subregion due to ongoing healthcare modernization and alignment with EU infection prevention standards
• •Product segmentation includes sterilizers, disinfectants, PPE, and reusable medical device reprocessing systems

What are the recent trends and outlook?

The market is expected to maintain a steady growth trajectory through the early 2030s, supported by continued regulatory tightening, aging populations requiring more medical interventions, and heightened pandemic preparedness priorities. Innovation in low-temperature sterilization technologies, single-use medical devices, and sustainable disinfectant formulations is shaping product development priorities. While economic headwinds and reimbursement pressures may moderate growth in certain segments, the long-term outlook remains positive as infection prevention continues to be a top priority for European healthcare systems.

• •Low-temperature sterilization technologies are gaining traction as minimally invasive surgical procedures using heat-sensitive instruments increase
• •Sustainability concerns are driving demand for environmentally friendly disinfectants and reduced single-use plastic consumables
• •Continued regulatory harmonization across EU member states is expected to sustain demand for compliant infection control products and services